Free tool
Heavily traded stocks
We cover 58 companies whose typical session turns over more than $10.00M. The median market value in the group is $6.22B. Across the group, the median move over the past trading day is +0.26%. 63% of the 56 with a 200-day average trade above it. Price change over the past year runs from −28.4% to +49.3% across the middle 80 percent of the group, with a median of +5.5%.
Other lists in this group
Table
58 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% | Oct 14, 2026 |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% | Oct 20, 2026 |
| ISRG | Intuitive Surgical, Inc. | $370.42 | +2.38% | −34.09% | −21.38% | Oct 20, 2026 |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% | Sep 1, 2026 |
| HCA | HCA Healthcare, Inc. | $427.16 | +2.14% | −9.06% | +5.96% | Oct 23, 2026 |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% | Oct 21, 2026 |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% | Oct 22, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% | Oct 22, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% | Oct 22, 2026 |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% | Aug 27, 2026 |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% | Oct 19, 2026 |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% | Sep 9, 2026 |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% | Oct 26, 2026 |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% | Oct 21, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% | Oct 26, 2026 |
| SMMT | Summit Therapeutics Inc. | $14.23 | +13.39% | −18.78% | −42.63% | Oct 19, 2026 |
| MOH | Molina Healthcare, Inc. | $199.63 | −0.35% | +11.86% | +13.35% | Oct 21, 2026 |
| UHS | Universal Health Services, Inc. | $178.69 | +7.50% | −18.65% | −1.76% | Oct 26, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% | Sep 21, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $12.22 | +4.18% | −11.83% | −14.19% | Oct 22, 2026 |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% | Sep 21, 2026 |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% | Oct 23, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% | Oct 13, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% | Oct 8, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% | Oct 1, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% | Oct 21, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% | Sep 14, 2026 |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% | Oct 15, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | 6,230.00 JPY | −9.58% | +14.30% | −22.48% | Oct 9, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% | Sep 23, 2026 |
| TLRY | Tilray Brands, Inc. | $4.64 | +15.14% | −52.26% | −66.13% | Oct 8, 2026 |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% | Sep 14, 2026 |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% | Aug 27, 2026 |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.